Literature DB >> 16494989

Purification of a post-synaptic neurotoxic phospholipase A2 from Naja naja venom and its inhibition by a glycoprotein from Withania somnifera.

Deepa K Machiah1, T Veerabasappa Gowda.   

Abstract

A post-synaptic neurotoxic phospholipase A(2) (PLA(2)) has been purified from Indian cobra Naja naja venom. It was associated with a peptide in the venom. The association was disrupted using 8 M urea. It is denoted to be a basic protein by its behavior on both ion exchange chromatography and electrophoresis. It is toxic to mice, LD(50) 1.9 mg/kg body weight (ip). It is proved to be post-synaptic PLA(2) by chymographic experiment using frog nerve-muscle preparation. A glycoprotein, (WSG) was isolated from a folk medicinal plant Withania somnifera. The WSG inhibited the phospholipase A(2) activity of NN-XIa-PLA(2,) isolated from the cobra venom, completely at a mole-to-mole ratio of 1:2 (NN-XIa-PLA(2): WSG) but failed to neutralize the toxicity of the molecule. However, it reduced the toxicity as well as prolonged the death time of the experimental mice approximately 10 times when compared to venom alone. The WSG also inhibited several other PLA(2) isoforms from the venom to varying extent. The interaction of the WSG with the PLA(2) is confirmed by fluorescence quenching and gel-permeation chromatography. Chemical modification of the active histidine residue of PLA(2) using p-brophenacyl bromide resulted in the loss of both catalytic activity as well as neurotoxicity of the molecule. These findings suggest that the venom PLA(2) has multiple sites on it; perhaps some of them are overlapping. Application of the plant extract on snakebite wound confirms the medicinal value associated with the plant.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16494989     DOI: 10.1016/j.biochi.2005.12.006

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  7 in total

Review 1.  Traditional use of plants against snakebite in Indian subcontinent: a review of the recent literature.

Authors:  Abhijit Dey; Jitendra Nath De
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-10-02

Review 2.  Plant-Derived Toxin Inhibitors as Potential Candidates to Complement Antivenom Treatment in Snakebite Envenomations.

Authors:  Asenate A X Adrião; Aline O Dos Santos; Emilly J S P de Lima; Jéssica B Maciel; Weider H P Paz; Felipe M A da Silva; Manuela B Pucca; Ana M Moura-da-Silva; Wuelton M Monteiro; Marco A Sartim; Hector H F Koolen
Journal:  Front Immunol       Date:  2022-05-09       Impact factor: 8.786

Review 3.  Pharmacologic overview of Withania somnifera, the Indian Ginseng.

Authors:  Nawab John Dar; Abid Hamid; Muzamil Ahmad
Journal:  Cell Mol Life Sci       Date:  2015-08-26       Impact factor: 9.261

Review 4.  Snake Venom PLA2, a Promising Target for Broad-Spectrum Antivenom Drug Development.

Authors:  Huixiang Xiao; Hong Pan; Keren Liao; Mengxue Yang; Chunhong Huang
Journal:  Biomed Res Int       Date:  2017-11-29       Impact factor: 3.411

5.  Withania somnifera as a potential future drug molecule for COVID-19.

Authors:  Vivek K Kashyap; Anupam Dhasmana; Murali M Yallapu; Subhash C Chauhan; Meena Jaggi
Journal:  Future Drug Discov       Date:  2020-10-01

Review 6.  Secreted Phospholipases A2 - not just Enzymes: Revisited.

Authors:  Adrijan Ivanušec; Jernej Šribar; Igor Križaj
Journal:  Int J Biol Sci       Date:  2022-01-01       Impact factor: 6.580

Review 7.  Neurotoxicity in snakebite--the limits of our knowledge.

Authors:  Udaya K Ranawaka; David G Lalloo; H Janaka de Silva
Journal:  PLoS Negl Trop Dis       Date:  2013-10-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.